Skip to content

healthcare AI

Every note that touches healthcare AI, newest first.

5 notesLatest All notes RSS feed

What to ask when patients discuss trust in healthcare AI

Thinking

A decision-specific interview approach keeps healthcare AI research tied to setting, action, expectations, and evidence limits.

Super Genius Labs Editorial · Oct 13, 2026 · 3 min read

What on-premise clinical AI evidence can support

Thinking

On-premise deployment can support institutional control, while clinical authority requires evidence tied to the proposed action.

Super Genius Labs Editorial · Sep 18, 2026 · 3 min read

Reading the ADVOCATE awards through seven evidence states

Thinking

A seven-state map helps operators distinguish ADVOCATE’s announced awards from authorization, deployment, and measured outcomes.

Super Genius Labs Editorial · Sep 16, 2026 · 3 min read

The FDA’s GenAI-device paper is a question set, not a compliance checklist

Thinking

FDA is considering a competency-based evaluation model for generative-AI medical devices. Its discussion paper offers diligence questions about the finished device, intended use, clinical confirmation, and postmarket monitoring, not adopted requirements.

Super Genius Labs Editorial · Aug 23, 2026 · 4 min read

What evidence should healthcare AI operators retain for non-device software?

Thinking

FDA’s patient-safety inquiry gives healthcare AI operators a bounded prompt. Preserve intended use, observed benefits, safety signals, implementation lessons, governance practices, and evidence ownership without treating an operational record as a legal classification or proof of safety.

Super Genius Labs Editorial · Aug 13, 2026 · 4 min read